The murine gene p27Kip1 is haplo-insufficient for tumour suppression

被引:669
作者
Fero, ML
Randel, E
Gurley, KE
Roberts, JM
Kemp, CJ
机构
[1] Fred Hutchinson Canc Res Ctr, Seattle, WA 98109 USA
[2] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA
关键词
D O I
10.1038/24179
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
p27(Kip) is a candidate human tumour-suppressor protein, because it is able to inhibit cyclin-dependent kinases and block cell proliferation(1-5). Abnormally low levels of the p27 protein are frequently found in human carcinomas, and these low levels correlate directly with both histological aggressiveness and patient mortality(6-10). However, it has not been possible to establish a causal link between p27 and tumour suppression, because only rare instances of homozygous inactivating mutations of the p27 gene have been found in human tumours(11-14). Thus, p27(Kip1) does not fulfil Knudson's 'two-mutation' criterion for a tumour-suppressor gene(15). Here we show that both p27 nullizygous and p27 heterozygous mice are predisposed to tumours in multiple tissues when challenged with gamma-irradiation or a chemical carcinogen. Therefore p27 is a multiple-tissue tumour suppressor in mice. Molecular analyses of tumours in p27 heterozygous mice show that the remaining wild-type allele is neither mutated nor silenced. Hence, p27 is haplo-insufficient for tumour suppression. The assumption that null mutations in tumour-suppressor genes are recessive excludes those genes that exhibit haplo-insufficiency.
引用
收藏
页码:177 / 180
页数:4
相关论文
共 30 条
[1]   DIAGONAL CUBIC EQUATIONS .2. [J].
BAKER, RC .
ACTA ARITHMETICA, 1989, 53 (03) :217-250
[2]  
BOUFFLER SD, 1995, CANCER RES, V55, P3883
[3]   THYMOCYTE APOPTOSIS INDUCED BY P53-DEPENDENT AND INDEPENDENT PATHWAYS [J].
CLARKE, AR ;
PURDIE, CA ;
HARRISON, DJ ;
MORRIS, RG ;
BIRD, CC ;
HOOPER, ML ;
WYLLIE, AH .
NATURE, 1993, 362 (6423) :849-852
[4]   Requirement of p27(Kip1) for restriction point control of the fibroblast cell cycle [J].
Coats, S ;
Flanagan, WM ;
Nourse, J ;
Roberts, JM .
SCIENCE, 1996, 272 (5263) :877-880
[5]   HOMOZYGOSITY OF CHROMOSOME 13 IN RETINOBLASTOMA [J].
DRYJA, TP ;
CAVENEE, W ;
WHITE, R ;
RAPAPORT, JM ;
PETERSEN, R ;
ALBERT, DM ;
BRUNS, GAP .
NEW ENGLAND JOURNAL OF MEDICINE, 1984, 310 (09) :550-553
[6]  
Esposito V, 1997, CANCER RES, V57, P3381
[7]   A syndrome of multiorgan hyperplasia with features of gigantism, tumorigenesis, and female sterility in p27(Kip1)-deficient mice [J].
Fero, ML ;
Rivkin, M ;
Tasch, M ;
Porter, P ;
Carow, CE ;
Firpo, E ;
Polyak, K ;
Tsai, LH ;
Broudy, V ;
Perlmutter, RM ;
Kaushansky, K ;
Roberts, JM .
CELL, 1996, 85 (05) :733-744
[8]   Transgenic mouse model for studying the transcriptional activity of the p53 protein: Age- and tissue-dependent changes in radiation-induced activation during embryogenesis [J].
Gottlieb, E ;
Haffner, R ;
King, A ;
Asher, G ;
Gruss, P ;
Lonai, P ;
Oren, M .
EMBO JOURNAL, 1997, 16 (06) :1381-1390
[9]   SPONTANEOUS AND CARCINOGEN-INDUCED TUMORIGENESIS IN P53-DEFICIENT MICE [J].
HARVEY, M ;
MCARTHUR, MJ ;
MONTGOMERY, CA ;
BUTEL, JS ;
BRADLEY, A ;
DONEHOWER, LA .
NATURE GENETICS, 1993, 5 (03) :225-229
[10]   Molecular analysis of cyclin-dependent kinase inhibitors in human leukemias [J].
Hayette, S ;
Thomas, X ;
Bertrand, Y ;
Tigaud, I ;
Callanan, M ;
Thiebaut, A ;
Charrin, C ;
Archimbaud, E ;
Magaud, JP ;
Rimokh, R .
LEUKEMIA, 1997, 11 (10) :1696-1699